BioAge Labs, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol: BIOA on Nasdaq
Industry: Pharmaceutical Preparations
Location: 1445 A South 50 Th Street, Richmond, CA

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+5.63K	100%	$18.00	+$101K
Sells	0
Net	+2	+5.63K	100%		+$101K

BioAge Labs, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Vijay Satyanand Pande	Director	$58.2M			Oct 1, 2024
James Healy	Director	$41.5M			Sep 25, 2024
Patrick G. Enright	Director	$30.8M			Sep 25, 2024
Cormorant Asset Management, LP	Former 10% Owner	$29.3M			Sep 27, 2024
Kristen Fortney	Chief Executive Officer, Director	$21.8M			Feb 18, 2025
Eric Morgen	Chief Operating Officer, Director	$1.21M			Feb 18, 2025
Dov A. Md Goldstein	Chief Financial Officer	$403K			Feb 18, 2025
Rekha Hemrajani	Director	$54K	+$54K		Sep 25, 2024
Shane Barton	Principal Accounting Officer	$47.4K	+$47.4K		Feb 18, 2025
Jean Pierre Garnier	Director				Sep 25, 2024
Paul D. Rubin	Chief Medical Officer				Feb 18, 2025
Michael H. Davidson	Director				Sep 25, 2024

Recent Insider Transactions by Companies or Individuals for BioAge Labs, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.